China cardiovascular diseases report 2018: an updated summary
- PMID: 32133031
- PMCID: PMC7008101
- DOI: 10.11909/j.issn.1671-5411.2020.01.001
China cardiovascular diseases report 2018: an updated summary
Keywords: Cardiovascular diseases; Heart failure; Risk factors.
Figures







Similar articles
-
Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction.Am J Med. 2015 Oct;128(10):1102-1108.e6. doi: 10.1016/j.amjmed.2015.04.042. Epub 2015 Jun 2. Am J Med. 2015. PMID: 26044936
-
Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials.Lancet Diabetes Endocrinol. 2020 May;8(5):418-435. doi: 10.1016/S2213-8587(20)30038-3. Lancet Diabetes Endocrinol. 2020. PMID: 32333878
-
Outline of the report on cardiovascular disease in China, 2010.Biomed Environ Sci. 2012 Jun;25(3):251-6. doi: 10.3967/0895-3988.2012.03.001. Biomed Environ Sci. 2012. PMID: 22840574
-
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure.J Cardiovasc Med (Hagerstown). 2011 Feb;12(2):76-84. doi: 10.2459/JCM.0b013e32834058d1. J Cardiovasc Med (Hagerstown). 2011. PMID: 20962666 Review.
-
Prognostic Implications of Congestion on Physical Examination Among Contemporary Patients With Heart Failure and Reduced Ejection Fraction: PARADIGM-HF.Circulation. 2019 Oct 22;140(17):1369-1379. doi: 10.1161/CIRCULATIONAHA.119.039920. Epub 2019 Sep 12. Circulation. 2019. PMID: 31510768 Clinical Trial.
Cited by
-
Enhanced stent visualization system for percutaneous coronary intervention in patients with chronic kidney disease: effects on contrast media volume and radiation exposure.BMC Cardiovasc Disord. 2022 Nov 16;22(1):487. doi: 10.1186/s12872-022-02930-0. BMC Cardiovasc Disord. 2022. PMID: 36380270 Free PMC article.
-
COVID-19 and cardiovascular comorbidities: An update.Rev Port Cardiol (Engl Ed). 2020 Aug;39(8):417-419. doi: 10.1016/j.repc.2020.06.013. Epub 2020 Jul 9. Rev Port Cardiol (Engl Ed). 2020. PMID: 32718858 Free PMC article. No abstract available.
-
A WeChat Mini Program-Based Intervention for Physical Activity, Fruit and Vegetable Consumption Among Chinese Cardiovascular Patients in Home-Based Rehabilitation: A Study Protocol.Front Public Health. 2022 Mar 22;10:739100. doi: 10.3389/fpubh.2022.739100. eCollection 2022. Front Public Health. 2022. PMID: 35392478 Free PMC article.
-
Immune-related potential biomarkers and therapeutic targets in coronary artery disease.Front Cardiovasc Med. 2023 Jan 6;9:1055422. doi: 10.3389/fcvm.2022.1055422. eCollection 2022. Front Cardiovasc Med. 2023. PMID: 36684561 Free PMC article.
-
Cardiovascular Disease Mortality and Potential Risk Factor in China: A Multi-Dimensional Assessment by a Grey Relational Approach.Int J Public Health. 2022 Apr 29;67:1604599. doi: 10.3389/ijph.2022.1604599. eCollection 2022. Int J Public Health. 2022. PMID: 35574277 Free PMC article.
References
-
- Wang Z, Chen Z, Zhang L, et al. Status of hypertension in china: Results from the China hypertension survey, 2012–2015. Circulation. 2018;137:2344–2356. - PubMed
-
- Dong B, Wang HJ, Wang Z, et al. The association of overweight and obesity with blood pressure among Chinese children and adolescents. Biomed Environ Sci. 2013;26:437–444. - PubMed
-
- Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196–203. - PubMed
-
- Pan L, Yang Z, Wu Y, et al. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis. 2016;248:2–9. - PubMed
LinkOut - more resources
Full Text Sources